vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.

Virgin Galactic Holdings, Inc is the larger business by last-quarter revenue ($4.2M vs $4.1M, roughly 1.0× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -2222.2%, a 2247.9% gap on every dollar of revenue. On growth, Virgin Galactic Holdings, Inc posted the faster year-over-year revenue change (125.5% vs -46.3%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.

MDAI vs SPCE — Head-to-Head

Bigger by revenue
SPCE
SPCE
1.0× larger
SPCE
$4.2M
$4.1M
MDAI
Growing faster (revenue YoY)
SPCE
SPCE
+171.8% gap
SPCE
125.5%
-46.3%
MDAI
Higher net margin
MDAI
MDAI
2247.9% more per $
MDAI
25.7%
-2222.2%
SPCE

Income Statement — Q4 FY2025 vs Q2 FY2024

Metric
MDAI
MDAI
SPCE
SPCE
Revenue
$4.1M
$4.2M
Net Profit
$1.1M
$-93.8M
Gross Margin
45.2%
-546.6%
Operating Margin
-54.9%
-2412.1%
Net Margin
25.7%
-2222.2%
Revenue YoY
-46.3%
125.5%
Net Profit YoY
113.9%
30.2%
EPS (diluted)
$0.04
$-4.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
SPCE
SPCE
Q4 25
$4.1M
Q3 25
$3.8M
Q2 25
$5.1M
Q1 25
$6.7M
Q4 24
$7.6M
Q3 24
$8.2M
Q2 24
$7.5M
$4.2M
Q1 24
$6.3M
$2.0M
Net Profit
MDAI
MDAI
SPCE
SPCE
Q4 25
$1.1M
Q3 25
$-3.6M
Q2 25
$-8.0M
Q1 25
$2.9M
Q4 24
$-7.6M
Q3 24
$-1.5M
Q2 24
$-2.9M
$-93.8M
Q1 24
$-3.2M
$-102.0M
Gross Margin
MDAI
MDAI
SPCE
SPCE
Q4 25
45.2%
Q3 25
42.7%
Q2 25
45.2%
Q1 25
47.2%
Q4 24
44.0%
Q3 24
44.9%
Q2 24
44.3%
-546.6%
Q1 24
46.6%
-1038.1%
Operating Margin
MDAI
MDAI
SPCE
SPCE
Q4 25
-54.9%
Q3 25
-88.1%
Q2 25
-41.9%
Q1 25
-13.4%
Q4 24
-14.6%
Q3 24
-10.8%
Q2 24
-32.7%
-2412.1%
Q1 24
-33.9%
-5599.9%
Net Margin
MDAI
MDAI
SPCE
SPCE
Q4 25
25.7%
Q3 25
-93.7%
Q2 25
-157.3%
Q1 25
43.2%
Q4 24
-99.8%
Q3 24
-18.4%
Q2 24
-38.3%
-2222.2%
Q1 24
-50.7%
-5139.1%
EPS (diluted)
MDAI
MDAI
SPCE
SPCE
Q4 25
$0.04
Q3 25
$-0.13
Q2 25
$-0.31
Q1 25
$0.11
Q4 24
$-0.42
Q3 24
$-0.08
Q2 24
$-0.16
$-4.36
Q1 24
$-0.19
$-5.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
SPCE
SPCE
Cash + ST InvestmentsLiquidity on hand
$15.4M
$775.7M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$394.8M
Total Assets
$21.4M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
SPCE
SPCE
Q4 25
$15.4M
Q3 25
$10.5M
Q2 25
$10.5M
Q1 25
$14.1M
Q4 24
$5.2M
Q3 24
$3.7M
Q2 24
$6.9M
$775.7M
Q1 24
$10.2M
$765.2M
Total Debt
MDAI
MDAI
SPCE
SPCE
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
SPCE
SPCE
Q4 25
$-5.7M
Q3 25
$-8.2M
Q2 25
$-9.2M
Q1 25
$-1.6M
Q4 24
$-7.3M
Q3 24
$-4.8M
Q2 24
$-4.7M
$394.8M
Q1 24
$-2.5M
$417.6M
Total Assets
MDAI
MDAI
SPCE
SPCE
Q4 25
$21.4M
Q3 25
$15.3M
Q2 25
$16.0M
Q1 25
$20.7M
Q4 24
$12.1M
Q3 24
$11.6M
Q2 24
$13.9M
$1.1B
Q1 24
$15.5M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
SPCE
SPCE
Operating Cash FlowLast quarter
$-2.6M
$-79.1M
Free Cash FlowOCF − Capex
$-113.5M
FCF MarginFCF / Revenue
-2690.7%
Capex IntensityCapex / Revenue
815.5%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters
$-458.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
SPCE
SPCE
Q4 25
$-2.6M
Q3 25
$-2.5M
Q2 25
$-3.4M
Q1 25
$-1.5M
Q4 24
$469.0K
Q3 24
$-1.6M
Q2 24
$-5.4M
$-79.1M
Q1 24
$-2.7M
$-113.2M
Free Cash Flow
MDAI
MDAI
SPCE
SPCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-113.5M
Q1 24
$-126.3M
FCF Margin
MDAI
MDAI
SPCE
SPCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-2690.7%
Q1 24
-6362.8%
Capex Intensity
MDAI
MDAI
SPCE
SPCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
815.5%
Q1 24
658.5%
Cash Conversion
MDAI
MDAI
SPCE
SPCE
Q4 25
-2.43×
Q3 25
Q2 25
Q1 25
-0.52×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons